House Subcommittee OK's FDA User Fee Bill; More Debate On Third-Party Servicers To Come
The House Energy and Commerce Health Subcommittee passed a bill reauthorizing FDA's device user fees May 18, along with amendments on over-the-counter (OTC) hearing aids and to streamline agency inspections of device facilities, among others. The subpanel agreed to shelve – for now – a proposed bill to facilitate off-label communications by medical product firms, and said they will wait for the full committee markup to debate a third-party servicers bill backed by imaging firms.
You may also be interested in...
Medtech firms are accustomed to rooting for House and Senate candidates they have backed in traditionally medtech-facility heavy regions of the US including Minnesota, Indiana and Massachusetts. As the sector grows in new regions, there are a broader set of important races for the industry, including in California, Texas, and New Jersey, this election season.
House Energy and Commerce Committee members added a slate of industry-favored device amendments into the FDA Reauthorization Act before sending the bill to the chamber floor, including reforms targeting device accessories, medical imaging and post-market surveillance.
The US Senate Health, Education, Labor, and Pensions Committee approved the FDA Reauthorization Act, reauthorizing drug and device user fees and multiple additions device regulation reforms, on a 21-2 vote. The mark-up session also gave HELP members from both parties a chance to vent about provisions they'd want to see in a Senate version of an Affordable Care Act repeal bill.